Despite excellent opportunities provided by animal models, it is essential to understand human disease especially one in which there are age-associated symptomatic differences. Parallel studies of patients and animal models with this disease will advance understanding of the biology, which in turn will lead to specific therapies. Information technology keeps educated parents and researchers on the fast track, and obligates clinicians to stay abreast of the advances to guide patients knowledgeably. The symposium held at the International Child Neurology Association Meeting in Beijing that is presented in this issue of the Journal of Child Neurology is an effort by the international researchers in Rett syndrome, and the parent organizations, the International Rett Syndrome Association (IRSA), and the Rett Syndrome Research Foundation (RSRF), to bring recent advances to the attention of pediatric neurologists who usually treat these patients. It is their hope that clinical and basic science researchers will be stimulated anew to participate in research in this disease, that is seen in all ethnic groups.
Professor Rett had difficulty convincing the neurological community of his day that the disease he described was a separate entity. Once that was achieved, his fervent desire was to see the discovery of the gene for the disorder named after him. Although this did not happen in his lifetime, he would be pleased that his excellent clinical judgment has created worldwide interest, keeping the scientific community animated.
